Indivior Pharmaceuticals (INDV) Shares Outstanding (Diluted) (2021 - 2026)
Indivior Pharmaceuticals (INDV) recorded Shares Outstanding (Diluted) of 124 million in Q2 2026, down 1.6% from 126 million a year earlier and down 3.9% from the prior quarter.
Powered by 
Analysis
Indivior Pharmaceuticals (INDV) Shares Outstanding (Diluted) (2021 - 2026) Analysis & Trends
For FY2025, Indivior Pharmaceuticals reported Shares Outstanding (Diluted) of 128 million, down 3.8% from FY2024.
- Annual Shares Outstanding (Diluted) has declined for four straight years, with a four-year compound annual growth rate of -4.2% (FY2021 to FY2025).
- Across earlier years, Shares Outstanding (Diluted) came in at 133 million in FY2024 (-2.9%), 137 million in FY2023 (-1.4%), 139 million in FY2022 (-8.5%) and 151.94 million in FY2021.
- The Q2 2026 figure is the lowest quarterly Shares Outstanding (Diluted) in data going back to Q4 2021.
- On a year-over-year basis, Shares Outstanding (Diluted) rose in 1 of the last seven quarters, with an average decline of 3.4%.
- Peak year-over-year performance for Shares Outstanding (Diluted) in the last five years was growth of 3.2% in Q1 2026, against a decline of 8.8% in Q1 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at 129 million (Q1 2026), 128 million (Q4 2025) and 129 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 2.44 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 1.96 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 1.56 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 544.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.24 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 5.70 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 255.20 Mn |
| 10 | Indivior Pharmaceuticals | 4.23 Bn | 3.19 Bn | 294.00 Mn | 124.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 124.00 Mn |
| Mar 31, 2026 | 129.00 Mn |
| Dec 31, 2025 | 128.00 Mn |
| Sep 30, 2025 | 129.00 Mn |
| Jun 30, 2025 | 126.00 Mn |
| Mar 31, 2025 | 125.00 Mn |
| Dec 31, 2024 | 133.00 Mn |
| Sep 30, 2024 | 133.00 Mn |
| Jun 30, 2024 | 135.00 Mn |
| Mar 31, 2024 | 137.00 Mn |
| Dec 31, 2023 | 137.00 Mn |
| Dec 31, 2022 | 139.00 Mn |
| Dec 31, 2021 | 151.94 Mn |
API Access
Indivior Pharmaceuticals Shares Outstanding (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=INDV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-diluted", "ticker": "INDV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=INDV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();